Product Code: ETC5293444 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
The Hong Kong SAR Nuclear Medicine Market is poised for steady growth rate improvements from 2025 to 2029. The growth rate starts at 0.01% in 2025 and reaches 0.06% by 2029.
The Nuclear Medicine market in Hong Kong SAR is projected to grow at a stable growth rate of 0.03% by 2027, highlighting the country's increasing focus on advanced technologies within the Asia region, where China holds the dominant position, followed closely by India, Japan, Australia and South Korea, shaping overall regional demand.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hong Kong Nuclear Medicine Market Overview |
3.1 Hong Kong Country Macro Economic Indicators |
3.2 Hong Kong Nuclear Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Hong Kong Nuclear Medicine Market - Industry Life Cycle |
3.4 Hong Kong Nuclear Medicine Market - Porter's Five Forces |
3.5 Hong Kong Nuclear Medicine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Hong Kong Nuclear Medicine Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 Hong Kong Nuclear Medicine Market Revenues & Volume Share, By Volume Assessment, 2021 & 2031F |
4 Hong Kong Nuclear Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases that require nuclear medicine for diagnosis and treatment |
4.2.2 Technological advancements in nuclear medicine imaging and therapy procedures |
4.2.3 Growing investments in healthcare infrastructure and research and development in Hong Kong |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and safety concerns related to nuclear medicine usage |
4.3.2 High cost associated with nuclear medicine equipment and procedures |
4.3.3 Limited awareness and understanding of nuclear medicine among healthcare professionals and patients in Hong Kong |
5 Hong Kong Nuclear Medicine Market Trends |
6 Hong Kong Nuclear Medicine Market Segmentations |
6.1 Hong Kong Nuclear Medicine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Hong Kong Nuclear Medicine Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2021-2031F |
6.1.3 Hong Kong Nuclear Medicine Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2021-2031F |
6.1.4 Hong Kong Nuclear Medicine Market Revenues & Volume, By Brachytherapy Isotopes, 2021-2031F |
6.2 Hong Kong Nuclear Medicine Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Hong Kong Nuclear Medicine Market Revenues & Volume, By Diagnostic Applications, 2021-2031F |
6.3 Hong Kong Nuclear Medicine Market, By Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 Hong Kong Nuclear Medicine Market Revenues & Volume, By Diagnostic Procedures, 2021-2031F |
6.3.3 Hong Kong Nuclear Medicine Market Revenues & Volume, By Therapeutic Procedures, 2021-2031F |
7 Hong Kong Nuclear Medicine Market Import-Export Trade Statistics |
7.1 Hong Kong Nuclear Medicine Market Export to Major Countries |
7.2 Hong Kong Nuclear Medicine Market Imports from Major Countries |
8 Hong Kong Nuclear Medicine Market Key Performance Indicators |
8.1 Number of nuclear medicine procedures performed annually |
8.2 Adoption rate of new nuclear medicine technologies in healthcare facilities |
8.3 Investment in nuclear medicine research and development in Hong Kong |
9 Hong Kong Nuclear Medicine Market - Opportunity Assessment |
9.1 Hong Kong Nuclear Medicine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Hong Kong Nuclear Medicine Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 Hong Kong Nuclear Medicine Market Opportunity Assessment, By Volume Assessment, 2021 & 2031F |
10 Hong Kong Nuclear Medicine Market - Competitive Landscape |
10.1 Hong Kong Nuclear Medicine Market Revenue Share, By Companies, 2024 |
10.2 Hong Kong Nuclear Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |